Legend: : Special Mention  : Important : Very Important : Key Development |
| |
 |
Strongyloidiasis--the most neglected of the neglected tropical diseases?
Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P, Trans R Soc Trop Med Hyg. 2009 Oct;103(10):967-72 |
| |
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection.
Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB, J Infect Dis. 2008 Aug 1;198(3):444-51 |
| |
DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.
LA Kerepesi, PB Keiser, TJ Nolan, GA Schad, D Abraham, TB Nutman, Infect Immun. 2005 Apr:2298-305 |
| |
Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics.
Agrawal V, Agarwal T, Ghoshal UC, Trans R Soc Trop Med Hyg. 2009 Mar;103(3):242-6 |
| |
The Strongyloides (Nematoda) of sheep and the predominant Strongyloides of cattle form at least two different, genetically isolated populations.
Eberhardt AG, Mayer WE, Bonfoh B, Streit A, Vet Parasitol. 2008 Oct 20;157(1-2):89-99 |
| |
Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
M Satoh, H Toma, S Kiyuna, Y Shiroma, A Kokaze, Y Sato, Am J Trop Med Hyg. 2004 Jul:107-11 |
| |
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
EM Carvalho, A Da Fonseca Porto, Parasite Immunol. 2004 Nov-Dec:487-97 |
| |
Intestinal damage in strongyloidiasis: the imbalance between cell death and proliferation.
AL Werneck-Silva, EP Alvares, P Gama, AO Damião, LH Osaki, D Ogias, AM Sipahi, Dig Dis Sci. 2006 Jun:1063-9 |
| |
Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
Jeyamani R, Joseph AJ, Chacko A, Trop Gastroenterol. 2007 Oct-Dec;28(4):176-7 |
| Supplementary evidence: |
| |
Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis of strongyloidiasis.
Anamnart W, Pattanawongsa A, Intapan PM, Maleewong W, J Clin Microbiol. 2010 Jan;48(1):97-100 |
| |
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
AC Kotze, S Clifford, J O'Grady, JM Behnke, JS McCarthy, Am J Trop Med Hyg. 2004 Nov:608-16 |
| |
Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody.
O Zaha, T Hirata, N Uchima, F Kinjo, A Saito, J Infect Chemother. 2004 Dec:348-51 |
| |
Comparison of enzyme-linked immunosorbent assay and indirect immunofluorescence assay in the diagnosis of human strongyloidiasis.
S Koosha, M Fesharaki, MB Rokni, Indian J Gastroenterol. 2004 Nov-Dec:214-6 |
| |
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.
S Lim, K Katz, S Krajden, M Fuksa, JS Keystone, KC Kain, CMAJ. 2004 Aug 31:479-84 |
| |
Displaced bacterial colonies indicating Strongyloides larval migration on agar plates.
MR Mariappan, O Vielemeyer, O Fadare, S Paventy, FJ Bia, Arch Pathol Lab Med. 2004 Jun:711-2 |
| |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
M Brown, M Kizza, C Watera, MA Quigley, S Rowland, P Hughes, JA Whitworth, AM Elliott, J Infect Dis. 2004 Nov 15:1869-79 |
| |
Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated
AF Porto, SB Santos, AL Muniz, V Basilio, W Rodrigues Jr, FA Neva, WO Dutra, KJ Gollob, S Jacobson, EM Carvalho, J Infect Dis. 2005 Feb 15:612-8 |
| |
Soil-transmitted helminthiases and health behaviors among schoolchildren and community members in a west-central border area of Thailand.
MT Anantaphruti, J Waikagul, W Maipanich, S Nuamtanong, S Pubampen, Southeast Asian J Trop Med Public Health. 2004 Jun:260-6 |
| |
Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature.
MW Schaeffer, JF Buell, M Gupta, GD Conway, SA Akhter, LE Wagoner, J Heart Lung Transplant. 2004 Jul:905-11 |
| |
Strongyloides stercoralis in the Immunocompromised Population.
PB Keiser, TB Nutman, Clin Microbiol Rev. 2004 Jan:208-17 |
| |
Strongyloides stercoralis infection as a manifestation of immune restoration syndrome.
AC Kim, HC Lupatkin, Clin Infect Dis. 2004 Aug 1:439-40 |
| |
Strongyloidiasis in children five years and below.
HO Dada-Adegbola, RA Bakare, West Afr J Med. 2004 Jul-Sep:194-7 |
| |
Strongyloidiasis.
K Asano, S Tada, T Kamio, T Matsumoto, H Suko, M Iida, Gastrointest Endosc. 2004 Oct:606-7 |
| |
Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia.
Z Gulbas, M Kebapci, O Pasaoglu, E Vardareli, South Med J. 2004 Sep:907-10 |
| |
The amphidial neuron pair ALD controls the temperature-sensitive choice of alternative developmental pathways in the parasitic nematode, Strongyloides stercoralis.
TJ Nolan, M Brenes, FT Ashton, X Zhu, WM Forbes, R Boston, GA Schad, Parasitology. 2004 Dec:753-9 |
| |
The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
P Muennig, D Pallin, C Challah, K Khan, Epidemiol Infect. 2004 Dec:1055-63 |
| |
The spectrum of GI strongyloidiasis: an endoscopic-pathologic study.
BF Thompson, LC Fry, CD Wells, M Olmos, DH Lee, AJ Lazenby, KE M&oeig;nkemuller, Gastrointest Endosc. 2004 Jun:906-10 |
| |
Treatment strategies in controlling strongyloidiasis.
M Satoh, A Kokaze, Expert Opin Pharmacother. 2004 Nov:2293-301 |
| |
Why does HIV infection not lead to disseminated strongyloidiasis?
ME Viney, M Brown, NE Omoding, JW Bailey, MP Gardner, E Roberts, D Morgan, AM Elliott, JA Whitworth, J Infect Dis. 2004 Dec 15:2175-80 |